Century Therapeutics (IPSC) Earnings Date & Reports

Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

IPSC is expected to report earnings to rise 12.16% to -41 cents per share on March 13

Century Therapeutics IPSC Stock Earnings Reports

Q4'24

Est.

$-0.41

Q3'24

Beat

by $0.08

Q2'24

Beat

by $0.07

Q1'24

Beat

by $0.06

Q4'23

Missed

by $0.11

The last earnings report on November 05 showed earnings per share of -37 cents, beating the estimate of -45 cents. With 5.32K shares outstanding, the current market capitalization sits at 51.97M.

View a ticker or compare two or three

Compare

IPSC